March 29, 2006 Citigroup Global Markets Inc. As Representative of the Initial Purchasers c/o Citigroup Global Markets Inc. 390 Greenwich Street New York, New York 10013 Ladies and Gentlemen: This Registration Rights Agreement (the "Agreement") is made...Registration Rights Agreement • March 30th, 2006 • King Pharmaceuticals Inc • Pharmaceutical preparations • New York
CONFORMED COPY CREDIT AGREEMENT Dated as of February 27, 1998, as amended and restated as of December 22, 1998Credit Agreement • March 31st, 1999 • King Pharmaceuticals Inc • Pharmaceutical preparations • New York
INDENTUREIndenture • April 27th, 1999 • King Pharmaceuticals Inc • Pharmaceutical preparations • New York
1 Exhibit C VOTING AGREEMENT THIS VOTING AGREEMENT (this "Agreement") is entered into this 30th day of November, 1999, by and among KING PHARMACEUTICALS, INC., a Tennessee corporation ("Acquiror"), MERLIN ACQUISITION I CORP., a Delaware corporation...Voting Agreement • December 21st, 1999 • King Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
BY AND AMONGAgreement and Plan of Merger • July 26th, 2004 • King Pharmaceuticals Inc • Pharmaceutical preparations • New York
BY AND AMONGAgreement and Plan of Merger • December 10th, 1999 • King Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
for Corgard(R) between BRISTOL-MYERS SQUIBB COMPANY as Seller, and KING PHARMACEUTICALS, INC. as PurchaserAsset Purchase Agreement • August 24th, 2001 • King Pharmaceuticals Inc • Pharmaceutical preparations • New York
ARTICLE IAsset Purchase Agreement • October 24th, 1997 • King Pharmaceuticals Inc • Missouri
RECITALSLicense Agreement • May 7th, 1998 • King Pharmaceuticals Inc • Pharmaceutical preparations • New York
AND THE BANK OF NEW YORK TRUST COMPANY, N.A., AS TRUSTEEKing Pharmaceuticals Inc • March 30th, 2006 • Pharmaceutical preparations • New York
February 26, 1999 Credit Suisse First Boston Corporation First Union Capital Markets Corp. Nationsbanc Montgomery Securities LLC c/o Credit Suisse First Boston Corporation Eleven Madison Avenue New York, New York 10010-3629 Dear Sirs: King...King Pharmaceuticals Inc • April 27th, 1999 • Pharmaceutical preparations • New York
CONFIDENTIALAsset Purchase Agreement • June 30th, 2000 • King Pharmaceuticals Inc • Pharmaceutical preparations • New York
NOVAVAX, INC. ANDNote Purchase Agreement • December 29th, 2000 • King Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
andKing Pharmaceuticals Inc • February 4th, 2002 • Pharmaceutical preparations • New York
LOAN AGREEMENTLoan Agreement • October 24th, 1997 • King Pharmaceuticals Inc • Tennessee
EXHIBIT 8 SECOND AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT THIS SECOND AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this "Agreement") is dated as of this 26th day of June, 2002, by and between NOVAVAX, INC., a Delaware corporation (the...Registration Rights Agreement • July 24th, 2002 • King Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
1 EXHIBIT 10.15 CREDIT AGREEMENTCredit Agreement • December 9th, 1997 • King Pharmaceuticals Inc • Pharmaceutical preparations • Georgia
FOURTH AMENDMENT ---------------- dated as of October 24, 2000 to theCredit Agreement • April 2nd, 2001 • King Pharmaceuticals Inc • Pharmaceutical preparations • New York
TOLL MANUFACTURING AGREEMENT FOR APAP/HYDROCODONE BITARTRATE TABLETSKing Pharmaceuticals Inc • December 9th, 1997 • Pharmaceutical preparations • Tennessee
1 EXHIBIT 10.10 LOAN AND SECURITY AGREEMENT BY AND BETWEEN KING PHARMACEUTICALS, INC., AS BORROWERLoan and Security Agreement • October 24th, 1997 • King Pharmaceuticals Inc • Tennessee
INDENTUREIndenture • July 3rd, 2001 • King Pharmaceuticals Inc • Pharmaceutical preparations • New York
EXHIBIT 10.20 CREDIT AGREEMENT Dated as of April 23, 2002,Credit Agreement • May 15th, 2002 • King Pharmaceuticals Inc • Pharmaceutical preparations • New York
KING PHARMACEUTICALS, INC. and UNION PLANTERS NATIONAL BANK Rights AgentRights Agreement • October 24th, 1997 • King Pharmaceuticals Inc • Tennessee
BY AND BETWEEN NOVAVAX, INC. ANDRegistration Rights Agreement • December 29th, 2000 • King Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
AGREEMENTSLoan Agreement • October 24th, 1997 • King Pharmaceuticals Inc • Tennessee
AGREEMENT FORAgreement • January 9th, 1998 • King Pharmaceuticals Inc • Pharmaceutical preparations • North Carolina
AGREEMENT FORAgreement • January 9th, 1998 • King Pharmaceuticals Inc • Pharmaceutical preparations • North Carolina
AGREEMENT FOR PURCHASE AND SALE OF ASSETS RELATING TO NEOSPORIN(R) AND POLYSPORIN(R) BY AND BETWEEN GLAXO WELLCOME INC. AND MONARCH PHARMACEUTICALS, INC.Agreement • January 9th, 1998 • King Pharmaceuticals Inc • Pharmaceutical preparations • North Carolina
EXHIBIT 10.2 COLLABORATIVE DEVELOPMENT AND MARKETING AGREEMENT This COLLABORATIVE DEVELOPMENT AND MARKETING AGREEMENT is entered into as of August 12, 2004 (the "Effective Date"), by and between PALATIN TECHNOLOGIES, INC., a Delaware corporation...Securities Purchase Agreement • March 21st, 2005 • King Pharmaceuticals Inc • Pharmaceutical preparations • New York
EXHIBIT 2.1 AMENDED AND RESTATED ASSET PURCHASE AGREEMENTAsset Purchase Agreement • June 13th, 2003 • King Pharmaceuticals Inc • Pharmaceutical preparations • New York
EXECUTION VERSION FIRST AMENDMENT dated as of March 22, 2006 (this "Amendment") to the CREDIT AGREEMENT dated as of April 23, 2002 (as amended, supplemented or otherwise modified from time to time, the "Credit Agreement"), among KING PHARMACEUTICALS,...Credit Agreement • March 28th, 2006 • King Pharmaceuticals Inc • Pharmaceutical preparations • New York
AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • October 12th, 2010 • King Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
AGREEMENT AND PLAN OF MERGER (this “Agreement”) dated as of October 11, 2010 among Pfizer Inc., a Delaware corporation (“Parent”), King Pharmaceuticals, Inc., a Tennessee corporation (the “Company”), and Parker Tennessee Corp., a Tennessee corporation and a subsidiary of Parent owned directly by Parent and/or indirectly by Parent through one or more of its wholly-owned subsidiaries (“Merger Sub”).
EXHIBIT 7 CONVERTIBLE NOTE THIS NOTE AND THE SHARES OF COMMON STOCK OF NOVAVAX, INC. (OR OTHER SECURITIES) WHICH MAY BE ISSUABLE AS INTEREST ON OR UPON CONVERSION OF THIS NOTE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE...Convertible Note • July 24th, 2002 • King Pharmaceuticals Inc • Pharmaceutical preparations
Exhibit 10.2 FIRST AMENDMENT TO RETIREMENT AND CONSULTING AGREEMENT THIS FIRST AMENDMENT (the "Amendment") to Retirement and Consulting Agreement between King Pharmaceuticals, Inc. ("Employer") and James R. Lattanzi ("Executive") dated April 1, 2005...Retirement and Consulting Agreement • February 15th, 2006 • King Pharmaceuticals Inc • Pharmaceutical preparations
MANUFACTURE AND SUPPLY AGREEMENT BETWEEN ROBERTS LABORATORIES INC. MERIDIAN CENTER II, 4 INDUSTRIAL WAY WEST EATONTOWN, NEW JERSEY, 07724 AND KING PHARMACEUTICALS, INC. 501 FIFTH STREET BRISTOL, TN 37620Manufacture and Supply Agreement • January 9th, 1998 • King Pharmaceuticals Inc • Pharmaceutical preparations • Tennessee
